Safety and effectiveness of vaccines against COVID-19 in children aged 5–11 years: a systematic review and meta-analysis
Covid19-Sources
Safety of the BNT162b2 COVID-19 Vaccine in Children Aged 5 to 17 Years
Vaccine Effectiveness Against Long COVID in Children
Effectiveness of Bivalent mRNA Vaccines in Preventing SARS-CoV-2 Infection in Children
Real-World Effectiveness of BNT162b2 Against Infection and Severe Diseases in Children and Adolescents | Annals of Internal Medicine
Millions of US Children Experience Range of Long COVID Effects
A synthesis of evidence for policy from behavioural science during COVID-19
Media celebrated Long COVID Awareness Day by denying its existence
Antibiotics can effectively target gut bacteria that harbor COVID-19 virus, study shows
COVID-19: Kein erhöhtes Schlaganfallrisiko nach bivalentem Booster
Zotero | LongCovid
Scientists may have found a biological basis for long COVID brain fog
Increased Infection Risks After COVID-19 Infections - WHN
Stressing personal ownership may be key to COVID booster uptake
Die Schattenfamilien der Pandemie: Ein Kampf ums Überleben
Experten rätseln über Ursache: Tödliche Infektion breitet sich in Japan aus
Frontiers | T4 apoptosis in the acute phase of SARS-CoV-2 infection predicts long COVID
Jeder dritte Infizierte unter 50 tot: Experten in Japan wegen rätselhafter Krankheit alarmiert
Blood transcriptomics reveal persistent SARS-CoV-2 RNA and candidate biomarkers in Long COVID patients
A novel, multitargeted endogenous metabolic modulator composition impacts metabolism, inflammation, and fibrosis in nonalcoholic steatohepatitis-relevant primary human cell models
AXA1125 - Wikipedia
Efficacy and tolerability of an endogenous metabolic modulator (AXA1125) in fatigue-predominant long COVID: a single-centre, double-blind, randomised controlled phase 2a pilot study
Long Covid, Post Covid, CFS: Urteil des OLG Hamm zur Berufsunfähigkeit stärkt Betroffenenrechte
SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency
(PDF) Differential Increases in Excess Mortality in the German Federal States During the COVID-19 Pandemic
Bremen 0.26% 2.19% 11.02%Hamburg 1.48% 2.16% 7.71%Hesse 3.87% 1.76% 7.94%Mecklenburg-Vorpommern -1.17% 4.92% 7.00%Lower Saxony -1.04% 0.56% 9.51%North Rhine-Westphalia 0.43% 1.95% 8.62%Rhineland-Palatinate -0.10% 1.62% 7.28%Saarland 0.40% 3.34% 10.86%Saxony 14.56% 6.34% 6.00%Saxony-Anhalt 5.04% 5.38% 8.39%Schleswig-Holstein -2.83% -1.02% 8.68%Thuringia 5.32% 7.95% 7.36%
Frontiers | Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning
Long Covid: Symptome und Behandlung bei Post Covid
The Delta variant SARS-CoV-2 spike protein uniquely promotes aggregation of pseudotyped viral particles
Zeitpunkt elektiver Eingriffe nach SARS-CoV-2-Infektion und Impfung